Literature DB >> 7004628

A fluorescent probe for rapid detection of estrogen receptors.

B R Rao, C G Fry, S Hunt, R Kuhnel, W B Dandliker.   

Abstract

Fluorescein conjugates to estradiol-17 beta by the sixth carbon (6-FE) and to estrone by the 17th carbon (17-FE) were used to detect estrogen receptors (ERs) in breast cancer tissue sections and in cultured cell lines (human mammary carcinoma MCF-7 and Copenhagen rat prostatic tumor R3327-AT). 17-FE was found to interact with ERs better than 6-FE by biochemical and histochemical techniques. Thin layer chromatography analysis of ethanolic extracts of 17-FE incorporated in tissues and cultured cells showed that over 95% of 17-FE was not metabolized. We concluded that the fluorescence observed in tissue sections and cultured cells was due to 17-FE and not to fluorescein dissociated from the conjugate. Analysis of 65 human breast cancer showed that 74% of the cases were positive for specific 17-FE uptake and 26% were negative. The fluorescence was consistently brighter in the ductal and glandular epithelial cells than in the stroma. specific 17-FE uptake in the nucleoli was observed in MCF-7 and in R3327-AT tumor cells in in vitro cultures, suggesting that these nucleolar estrogen receptors may play a key role in the mechanism of estrogen action. Problems of fluorescence quantitation in tissue sections and cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004628     DOI: 10.1002/1097-0142(19801215)46:12+<2902::aid-cncr2820461432>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Biochemical assessment of histochemical methods for oestrogen receptor localisation.

Authors:  J C Underwood; E Sher; M Reed; J A Eisman; T J Martin
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

2.  Estrogen receptors in human breast cancer detected by the fluorescent estradiol histochemical and dextran coated charcoal techniques.

Authors:  M Nishiki; K Amano; M Yamane; T Okumichi; H Ezaki
Journal:  Jpn J Surg       Date:  1984-11

3.  Fluorescent ligands, used in histocytochemistry, do not discriminate between estrogen receptor-positive and receptor-negative human tumor cell lines.

Authors:  E M Berns; E Mulder; F F Rommerts; R A Blankenstein; E de Graaf; H J van der Molen
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: a reappraisal.

Authors:  L P Pertschuk; E H Tobin; A C Carter; K B Eisenberg; V C Leo; E Gaetjens; N D Bloom
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Synthesis and pharmacological characterization of fluorescent opioid receptor probes.

Authors:  V M Kolb; A D Koman; A Neil
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.